Loading

Creating successful academic-industry collaborations

10 Feb 2026
Theatre 4
Commercial strategy and global access

Collaboration between academia and industry remains critical to translating early research into viable advanced therapy medicinal products (ATMPs). This discussion examines partnership frameworks, funding approaches, and governance models that enable productive alignment between scientific innovation and development priorities.

Key takeaways

  • Examine how academic and industry partners define shared objectives and research milestones.
  • Identify governance structures that balance scientific independence with commercial timelines.
  • Explore funding and licensing mechanisms that promote long-term collaboration.
  • Discuss how to manage intellectual property and data transparency in joint programs.
  • Learn from practical examples at Deerfield and NKILT Therapeutics of successful partnership models.
Speakers
Andrew Steinsapir, Director, Gene Therapy Program Lead - Deerfield Management
Raphael Ognar, Chief Executive Officer - NKILT Therapeutics